Articles related to DRUG COSTS
Despite Discounts, Insulin Prices Remain High
The study’s findings underscore the importance of addressing the high cost of insulin. Despite new products and discounts entering the market, one in four patients still report cost as a barrier to accessing their necessary insulin.
Clinical Pharmacology October 30th 2023
Huge Spike in Prior Authorization for Cancer Drugs Leaves Docs “Shouting in the Wind”
New research underscores the dramatic increase in prior authorization for oral oncology drugs under Medicare Part D. Understand the implications for your practice as insurers tighten their grip on treatment decisions.
Hematology/Oncology September 5th 2023
HHS Selects First 10 Drugs for Medicare Drug Price Negotiation; Policy Faces Multiple Legal Challenges From Pharma
The HHS has initiated a landmark policy to negotiate drug prices under Medicare Part D. Be prepared for how these changes could affect your patients’ medication affordability starting in 2026.
Clinical Pharmacology August 31st 2023